Select Issuer Clients

Select Issuer Clients

Issuer Client Profile

DarioHealth Corp. (DRIO)

DarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™ mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease.

View Website

Stock Info

DarioHealth Corp. DRIO
Volume
Day Range
52 wk Range
Market Cap

Stock Quotes are delayed at least 15 minutes.

Issuer Client News Feed